Publications
Detailed Information
RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Kyung-Hun | - |
dc.contributor.author | Hur, Hyung-Seok | - |
dc.contributor.author | Im, Seock-Ah | - |
dc.contributor.author | Lee, Juhee | - |
dc.contributor.author | Kim, Hwang-Phill | - |
dc.contributor.author | Yoon, Young-Kwang | - |
dc.contributor.author | Han, Sae-Won | - |
dc.contributor.author | Song, Sang-Hyun | - |
dc.contributor.author | Oh, Do-Youn | - |
dc.contributor.author | Kim, Tae-You | - |
dc.contributor.author | Bang, Yung-Jue | - |
dc.date.accessioned | 2012-06-28T02:07:58Z | - |
dc.date.available | 2012-06-28T02:07:58Z | - |
dc.date.created | 2017-11-15 | - |
dc.date.created | 2017-11-15 | - |
dc.date.issued | 2010-12-18 | - |
dc.identifier.citation | Cancer Letters, Vol.299 No.1, pp.22-28 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.other | 2442 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77724 | - |
dc.description.abstract | We evaluated RAD001 an inhibitor of the mammalian target of rapamycin (mTOR) in human gastric cancer cell lines and determined the molecular mechanisms RAD001 has marked growth inhibitory activity against the SNU-1 and SNU-216 cells It inhibited phosphorylation of mTOR and S6 K and induced Cl cell cycle arrest Synergistic growth inhibitory effects in combination with 5-fluorouracil (5-FU) was identified Furthermore RAD001 conferred sensitivity to 5-FU-resistant cell lines by downregulating thymidylate synthase (TS) In conclusion RAD001 showed growth inhibitory activity against gastric cancer cells and acted synergistically with cytotoxic agents such as 5-FU by downregulating TS (C) 2010 Elsevier Ireland Ltd All rights reserved | - |
dc.language | 영어 | - |
dc.language.iso | en | ko_KR |
dc.publisher | Elsevier BV | - |
dc.title | RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 임석아 | - |
dc.identifier.doi | 10.1016/j.canlet.2010.07.020 | - |
dc.citation.journaltitle | Cancer Letters | - |
dc.description.citedreference | CHON HJ, 2009, CANC RES TREAT, V41, P196 | - |
dc.description.citedreference | Cejka D, 2008, ANTICANCER RES, V28, P3801 | - |
dc.description.citedreference | Kim HP, 2008, MOL CANCER THER, V7, P607, DOI 10.1158/1535-7163.MCT-07-2068 | - |
dc.description.citedreference | CEJKA D, 2008, CANCER BIOL THER, V7, P1377 | - |
dc.description.citedreference | Pandyra AA, 2007, J PHARMACOL EXP THER, V322, P123, DOI 10.1124/jpet.106.115394 | - |
dc.description.citedreference | Lang SA, 2007, INT J CANCER, V120, P1803, DOI 10.1002/ijc.22442 | - |
dc.description.citedreference | Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990 | - |
dc.description.citedreference | Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419 | - |
dc.description.citedreference | Xi YG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-68 | - |
dc.description.citedreference | Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016 | - |
dc.description.citedreference | O`Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925 | - |
dc.description.citedreference | Oki E, 2005, INT J CANCER, V117, P376, DOI 10.1002/ijc.21170 | - |
dc.description.citedreference | Ajani JA, 2005, J CLIN ONCOL, V23, P5660, DOI 10.1200/JCO.2005.17.376 | - |
dc.description.citedreference | Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113 | - |
dc.description.citedreference | Beuvink I, 2005, CELL, V120, P747 | - |
dc.description.citedreference | Kang HJ, 2005, BRIT J CANCER, V92, P246, DOI 10.1038/sj.bjc.6602336 | - |
dc.description.citedreference | Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362 | - |
dc.description.citedreference | Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542 | - |
dc.description.citedreference | Panwalkar A, 2004, CANCER-AM CANCER SOC, V100, P657, DOI 10.1002/cncr.20026 | - |
dc.description.citedreference | Noh WC, 2004, CLIN CANCER RES, V10, P1013 | - |
dc.description.citedreference | Sawyers CL, 2003, CANCER CELL, V4, P343 | - |
dc.description.citedreference | Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9 | - |
dc.description.citedreference | Huang SL, 2003, CANCER BIOL THER, V2, P222 | - |
dc.description.citedreference | Mizutani Y, 2003, CLIN CANCER RES, V9, P1453 | - |
dc.description.citedreference | Kawate H, 2002, J BIOL CHEM, V277, P36304, DOI 10.1074/jbc.M204956200 | - |
dc.description.citedreference | Nomura T, 2002, INT J UROL, V9, P368 | - |
dc.description.citedreference | Saga Y, 2002, ONCOLOGY-BASEL, V63, P185 | - |
dc.description.citedreference | Garber K, 2001, J NATL CANCER I, V93, P1517 | - |
dc.description.citedreference | Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314 | - |
dc.description.citedreference | LEICHMAN L, 2001, EUR J SURG S, P43 | - |
dc.description.citedreference | Hidalgo M, 2000, ONCOGENE, V19, P6680 | - |
dc.description.citedreference | Park JG, 1997, INT J CANCER, V70, P443 | - |
dc.description.citedreference | COPUR S, 1995, BIOCHEM PHARMACOL, V49, P1419 | - |
dc.description.citedreference | JOHNSTON PG, 1995, CANCER RES, V55, P1407 | - |
dc.description.citedreference | CHOU TC, 1994, J NATL CANCER I, V86, P1517 | - |
dc.description.citedreference | PARK JG, 1987, CANCER RES, V47, P5875 | - |
dc.description.citedreference | CHOU TC, 1984, ADV ENZYME REGUL, V22, P27 | - |
dc.description.tc | 6 | - |
dc.identifier.wosid | 000284516800003 | - |
dc.identifier.scopusid | 2-s2.0-77957891539 | - |
dc.citation.endpage | 28 | - |
dc.citation.number | 1 | - |
dc.citation.startpage | 22 | - |
dc.citation.volume | 299 | - |
dc.identifier.sci | 000284516800003 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Im, Seock-Ah | - |
dc.contributor.affiliatedAuthor | Oh, Do-Youn | - |
dc.contributor.affiliatedAuthor | Kim, Tae-You | - |
dc.contributor.affiliatedAuthor | Bang, Yung-Jue | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | MAMMALIAN TARGET | - |
dc.subject.keywordPlus | COLON-CANCER | - |
dc.subject.keywordPlus | PHASE-II | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | RAPAMYCIN | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | LINES | - |
dc.subject.keywordPlus | 5-FLUOROURACIL | - |
dc.subject.keywordAuthor | Gastric cancer | - |
dc.subject.keywordAuthor | RAD001 | - |
dc.subject.keywordAuthor | mTOR | - |
dc.subject.keywordAuthor | Thymidylate synthase | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.